The Assessment of Endothelial Function: From Research Into Clinical Practice
暂无分享,去创建一个
T. Lüscher | P. Ganz | M. Creager | A. Lerman | D. Celermajer | J. Deanfield | M. Shechter | S. Taddei | N. Hamburg | J. Vita | T. Anderson | A. Flammer
[1] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[2] J. Jukema,et al. Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial. , 2012, European heart journal.
[3] T. Münzel,et al. Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease. , 2012, European heart journal.
[4] D. Leong,et al. Coronary β2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study. , 2012, European heart journal.
[5] Ahmed Tawakol,et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial , 2011, The Lancet.
[6] N. Koren-Morag,et al. The impact of early compared to late morning hours on brachial endothelial function and long-term cardiovascular events in healthy subjects with no apparent coronary heart disease. , 2011, International journal of cardiology.
[7] R. Schnabel,et al. Noninvasive Vascular Function Measurement in the Community: Cross-Sectional Relations and Comparison of Methods , 2011, Circulation. Cardiovascular imaging.
[8] M. G. Modena,et al. Endothelial function affects early carotid atherosclerosis progression in hypertensive postmenopausal women , 2011, Journal of hypertension.
[9] A. Quyyumi,et al. Endothelium-Derived Hyperpolarizing Factor Determines Resting and Stimulated Forearm Vasodilator Tone in Health and in Disease , 2011, Circulation.
[10] L. Lind,et al. Endothelial Function in Resistance and Conduit Arteries and 5-Year Risk of Cardiovascular Disease , 2011, Circulation.
[11] T. Münzel,et al. Flow-mediated constriction: further insight into a new measure of vascular function. , 2011, European heart journal.
[12] P. Thompson,et al. Heterogenous vasodilator pathways underlie flow‐mediated dilation in men and women , 2011, American journal of physiology. Heart and circulatory physiology.
[13] L. Lerman,et al. Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[14] D. Leung,et al. Significance and assessment of coronary microvascular dysfunction , 2011, Heart.
[15] D. Levy,et al. Relation of Brachial and Digital Measures of Vascular Function in the Community: The Framingham Heart Study , 2011, Hypertension.
[16] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.
[17] E. Lonn,et al. Microvascular Function Predicts Cardiovascular Events in Primary Prevention: Long-Term Results From the Firefighters and Their Endothelium (FATE) Study , 2011, Circulation.
[18] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.
[19] J. Kastelein,et al. Assessment of atherosclerosis: the role of flow-mediated dilatation. , 2010, European heart journal.
[20] T. Lüscher,et al. Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases. , 2010, Swiss medical weekly.
[21] V. Dilsizian,et al. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. , 2010, JACC. Cardiovascular imaging.
[22] A. Kastrati,et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. , 2010, Journal of the American College of Cardiology.
[23] Ryan A. Harris,et al. Ultrasound Assessment of Flow-Mediated Dilation , 2010, Hypertension.
[24] R. Rubinshtein,et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. , 2010, European heart journal.
[25] S. Umemura,et al. Digital assessment of endothelial function and ischemic heart disease in women. , 2010, Journal of the American College of Cardiology.
[26] T. Lüscher,et al. Human endothelial dysfunction: EDRFs , 2010, Pflügers Archiv - European Journal of Physiology.
[27] M. Félétou,et al. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis , 2010, Pflügers Archiv - European Journal of Physiology.
[28] N. Hamburg,et al. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications , 2010, Reviews in Endocrine and Metabolic Disorders.
[29] P. Vanhoutte,et al. Endothelial dysfunction: a strategic target in the treatment of hypertension? , 2010, Pflügers Archiv - European Journal of Physiology.
[30] G. Hobbs,et al. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis. , 2010, The American journal of cardiology.
[31] L. Ghiadoni,et al. Human endothelial dysfunction: EDCFs , 2010, Pflügers Archiv - European Journal of Physiology.
[32] J. Deanfield,et al. The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs , 2009, Current opinion in lipidology.
[33] T. Gori,et al. Assessment of vascular function: flow-mediated constriction complements the information of flow-mediated dilatation , 2009, Heart.
[34] D. Green,et al. Exercise Training as Vascular Medicine: Direct Impacts on the Vasculature in Humans , 2009, Exercise and sport sciences reviews.
[35] David M. Herrington,et al. Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in a Population-Based Study: The Multi-Ethnic Study of Atherosclerosis , 2009, Circulation.
[36] S. Kaser,et al. Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis. , 2009, European heart journal.
[37] D. Holmes,et al. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques , 2009, Heart.
[38] D. Freimark,et al. Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure † , 2009, European journal of heart failure.
[39] E. Lonn,et al. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. , 2009, The American journal of cardiology.
[40] T. Lüscher,et al. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study , 2009, European heart journal.
[41] N. Koren-Morag,et al. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. , 2009, International journal of cardiology.
[42] C. Giannarelli,et al. Effect of Sulfaphenazole on Tissue Plasminogen Activator Release in Normotensive Subjects and Hypertensive Patients , 2009, Circulation.
[43] T. Lüscher,et al. Cocoa and Cardiovascular Health , 2009, Circulation.
[44] M. Marmot,et al. Endothelial Function Predicts Progression of Carotid Intima-Media Thickness , 2009, Circulation.
[45] F. Crea,et al. Advances in coronary microvascular dysfunction. , 2009, Heart, lung & circulation.
[46] Takamitsu Nakamura,et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. , 2009, Journal of the American College of Cardiology.
[47] P. Ganz,et al. Individualized approach to the management of coronary heart disease: identifying the nonresponders before it is too late. , 2009, Journal of the American College of Cardiology.
[48] Helen Jones,et al. Changes in vascular and cardiac function after prolonged strenuous exercise in humans. , 2008, Journal of applied physiology.
[49] D. Thijssen,et al. Heterogeneity in conduit artery function in humans: impact of arterial size. , 2008, American journal of physiology. Heart and circulatory physiology.
[50] E. Meaney,et al. METFORMIN, ARTERIAL FUNCTION, INTIMA–MEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY , 2008, Clinical and experimental pharmacology & physiology.
[51] M. Hersberger,et al. Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial , 2008, Heart.
[52] B. Meiser,et al. Impact of Coronary Endothelial Dysfunction on Adverse Long-Term Outcome After Heart Transplantation , 2008, Transplantation.
[53] T. Gori,et al. Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. , 2008, Journal of the American College of Cardiology.
[54] T. Cole,et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. , 2008, Journal of the American College of Cardiology.
[55] Ramachandran S Vasan,et al. Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study , 2008, Circulation.
[56] S. Glantz,et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. , 2008, Journal of the American College of Cardiology.
[57] M. G. Modena,et al. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. , 2008, Journal of the American College of Cardiology.
[58] L. Prisant. Nebivolol: Pharmacologic Profile of an Ultraselective, Vasodilatory β1‐Blocker , 2008, Journal of clinical pharmacology.
[59] F. Ruschitzka,et al. Dark Chocolate Improves Coronary Vasomotion and Reduces Platelet Reactivity , 2007, Circulation.
[60] J. Raffetto,et al. Predictive Value of Reactive Hyperemia for Cardiovascular Events in Patients With Peripheral Arterial Disease Undergoing Vascular Surgery , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[61] Shah Ebrahim,et al. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .
[62] E. Edelman,et al. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. , 2007, Journal of the American College of Cardiology.
[63] K. Wolski,et al. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. , 2007, The New England journal of medicine.
[64] G. Taffet,et al. Coronary Microvascular Dysfunction , 2007 .
[65] L. Lerman,et al. Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease , 2007, Circulation.
[66] F. Hsu,et al. Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in Older Adults: The Cardiovascular Health Study , 2007, Circulation.
[67] B. Gersh,et al. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? , 2007, European heart journal.
[68] F. Ruschitzka,et al. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension , 2007, Journal of hypertension.
[69] M. Hanefeld,et al. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study. , 2007, Journal of the American College of Cardiology.
[70] G. Kundt,et al. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. , 2006, Journal of the American College of Cardiology.
[71] L. Ghiadoni,et al. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. , 2006, Journal of the American College of Cardiology.
[72] Marie Gerhard-Herman,et al. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. , 2006, Journal of applied physiology.
[73] D. Freimark,et al. Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease. , 2006, The American journal of cardiology.
[74] T. Celik,et al. Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction , 2006, Coronary artery disease.
[75] T. Lüscher,et al. Protection of Endothelial Function: Targets for Nutritional and Pharmacological Interventions , 2006, Journal of cardiovascular pharmacology.
[76] D. Giugliano,et al. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. , 2006, Diabetes care.
[77] C. Napoli,et al. Chronic Antioxidant Supplementation Impairs Coronary Endothelial Function and Myocardial Perfusion in Normal Pigs , 2006, Hypertension.
[78] Elaine Warner,et al. Cross-Sectional Relations of Peripheral Microvascular Function, Cardiovascular Disease Risk Factors, and Aortic Stiffness: The Framingham Heart Study , 2005, Circulation.
[79] T. Niendorf,et al. Blood Oxygen Level–Dependent MRI of Tissue Oxygenation: Relation to Endothelium-Dependent and Endothelium-Independent Blood Flow Changes , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[80] E. Lonn,et al. Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. , 2005, Journal of the American College of Cardiology.
[81] G. Smith,et al. Endothelial Dysfunction in Childhood Infection , 2005, Circulation.
[82] B. Gersh,et al. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. , 2005, European heart journal.
[83] M. Singer,et al. Inflammation and Endothelial Function: Direct Vascular Effects of Human C-Reactive Protein on Nitric Oxide Bioavailability , 2005, Circulation.
[84] A. Zeiher,et al. Endothelial Function: Cardiac Events , 2005, Circulation.
[85] C. Apovian,et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. , 2005, The American journal of cardiology.
[86] V. Pasceri,et al. Impaired Flow-Mediated Dilation and Risk of Restenosis in Patients Undergoing Coronary Stent Implantation , 2005, Circulation.
[87] Amir Lerman,et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. , 2004, Journal of the American College of Cardiology.
[88] J. Viikari,et al. Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study , 2004, Circulation.
[89] M. G. Modena,et al. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. , 2004, Journal of the American College of Cardiology.
[90] S. Fichtlscherer,et al. Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary Syndromes: Further Evidence for the Existence of the “Vulnerable” Patient , 2004, Circulation.
[91] K. Pyke,et al. Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans. , 2004, Journal of applied physiology.
[92] D. Levy,et al. Local Shear Stress and Brachial Artery Flow–Mediated Dilation: The Framingham Heart Study , 2004, Hypertension.
[93] B. Gersh,et al. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. , 2004, American heart journal.
[94] J. Morrow,et al. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. , 2004, Journal of the American College of Cardiology.
[95] H. Hod,et al. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. , 2003, Journal of the American College of Cardiology.
[96] Tom Fahey,et al. Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study , 2003, BMJ : British Medical Journal.
[97] A. Ignaszewski,et al. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. , 2003, Journal of the American College of Cardiology.
[98] T. Lüscher,et al. ETA Receptors Mediate Vasoconstriction of Large Conduit Arteries During Reduced Flow in Humans , 2003, Journal of cardiovascular pharmacology.
[99] K. Nishioka,et al. Diabetes mellitus is associated with insufficient microvascular reperfusion following revascularization for anterior acute myocardial infarction. , 2003, Internal medicine.
[100] E. Martin,et al. The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[101] I. Porto,et al. Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation , 2003, Heart.
[102] Ayan R Patel,et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. , 2003, American heart journal.
[103] Amir Lerman,et al. Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events , 2003, Circulation.
[104] Amir Lerman,et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. , 2003, Journal of the American College of Cardiology.
[105] M. Pfisterer,et al. Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[106] T. Lüscher,et al. High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells: Role of Protein Kinase C and Reactive Oxygen Species , 2003, Circulation.
[107] Amir Lerman,et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[108] Encore Investigators. Effect of Nifedipine and Cerivastatin on Coronary Endothelial Function in Patients With Coronary Artery Disease: The ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function) , 2003, Circulation.
[109] Shing‐Jong Lin,et al. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. , 2002, The American journal of cardiology.
[110] F. Ruschitzka,et al. Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis , 2002 .
[111] E. Antman,et al. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. , 2002, American heart journal.
[112] N. Alpert,et al. Homocysteine impairs coronary microvascular dilator function in humans. , 2002, Journal of the American College of Cardiology.
[113] F. Coppi,et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. , 2002, Journal of the American College of Cardiology.
[114] A. Quyyumi,et al. Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.
[115] L. Klein,et al. Coronary Endothelial Dysfunction After Heart Transplantation Predicts Allograft Vasculopathy and Cardiac Death , 2002, Circulation.
[116] P. Serruys,et al. Coronary Flow Velocity Reserve After Percutaneous Interventions Is Predictive of Periprocedural Outcome , 2002, Circulation.
[117] M. Watkins,et al. Risk Stratification for Postoperative Cardiovascular Events via Noninvasive Assessment of Endothelial Function: A Prospective Study , 2002, Circulation.
[118] B. Blauhut. Society Bulletins · Gesellschaftsmitteilungen , 2002, Transfusion Medicine and Hemotherapy.
[119] F. Ruschitzka,et al. High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men , 2002, Circulation.
[120] E. Benjamin,et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.
[121] T. Meinertz,et al. Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.
[122] L. Ghiadoni,et al. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. , 2001, Journal of the American College of Cardiology.
[123] J. Trochu,et al. Role of Endothelium-Derived Nitric Oxide in the Regulation of Cardiac Oxygen Metabolism: Implications in Health and Disease , 2000, Circulation research.
[124] J. Forrester,et al. Oral Magnesium Therapy Improves Endothelial Function in Patients With Coronary Artery Disease , 2000, Circulation.
[125] K. Okumura,et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. , 2000, Journal of the American College of Cardiology.
[126] A. Yeung,et al. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. , 2000, Circulation.
[127] K. Kostner,et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. , 2000, The American journal of cardiology.
[128] Peretz Lavie,et al. Peripheral vasoconstriction during REM sleep detected by a new plethysmographic method , 2000, Nature Medicine.
[129] G. Garcı́a-Cardeña,et al. Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis a , 2000, Annals of the New York Academy of Sciences.
[130] A M Zeiher,et al. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.
[131] J. Keaney,et al. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. , 2000, Hypertension.
[132] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[133] G. Schuler,et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. , 2000, The New England journal of medicine.
[134] F. Ohsuzu,et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. , 1998, The American journal of cardiology.
[135] StephanGielen,et al. Regular Physical Exercise Corrects Endothelial Dysfunction and Improves Exercise Capacity in Patients With Chronic Heart Failure , 1998 .
[136] L. Ghiadoni,et al. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. , 1998, Circulation.
[137] L. Ghiadoni,et al. Effects of angiotensin converting enzyme inhibition on endothelium‐dependent vasodilatation in essential hypertensive patients , 1998, Journal of hypertension.
[138] Katherine C. Wu,et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.
[139] L S Murray,et al. How reproducible is bilateral forearm plethysmography? , 1998, British journal of clinical pharmacology.
[140] L. Ghiadoni,et al. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. , 1997, Hypertension.
[141] G. Plotnick,et al. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.
[142] R. Gibbons,et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. , 1997, Circulation.
[143] A. Yeung,et al. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. , 1996, The American journal of cardiology.
[144] P. Groop,et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. , 1996, Circulation.
[145] L. Ghiadoni,et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. , 1996, Circulation.
[146] A. Takeshita,et al. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. , 1996, Circulation research.
[147] A. Baron,et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.
[148] G. B. John Mancini,et al. Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .
[149] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[150] T Bull,et al. Exercise training enhances endothelial function in young men. , 1996, Journal of the American College of Cardiology.
[151] T. Lüscher,et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. , 1996, Circulation.
[152] A. Yeung,et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. , 1996, Circulation.
[153] J. Deanfield,et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.
[154] A. Yeung,et al. Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.
[155] A. Zeiher,et al. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. , 1995, Circulation.
[156] W. Haefeli,et al. Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans. , 1995, Hypertension.
[157] P Vallance,et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. , 1995, Hypertension.
[158] W E Haefeli,et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. , 1995, Circulation.
[159] W. Weintraub,et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.
[160] P. Ganz,et al. Systemic nature of endothelial dysfunction in atherosclerosis. , 1995, The American journal of cardiology.
[161] A. Yeung,et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.
[162] A. Quyyumi,et al. The Role of Nitric Oxide in Endothelium‐Dependent Vasodilation of Hypercholesterolemic Patients , 1993, Circulation.
[163] D. Celermajer,et al. Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.
[164] P. Smits,et al. Endothelium-Dependent Vascular Relaxation in Patients With Type I Diabetes , 1993, Diabetes.
[165] P. Vallance,et al. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. , 1992, The Journal of clinical investigation.
[166] J. K. Lloyd,et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.
[167] E. Nabel,et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. , 1992, Circulation research.
[168] A. Yeung,et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.
[169] A. Lerman,et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. , 1991, The New England journal of medicine.
[170] P. Ganz,et al. Early evidence of endothelial vasodilator dysfunction at coronary branch points. , 1990, Circulation.
[171] E. Nabel,et al. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. , 1990, Journal of the American College of Cardiology.
[172] A. Quyyumi,et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. , 1990, The New England journal of medicine.
[173] T. Lüscher,et al. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. , 1990, Circulation.
[174] E. Nabel,et al. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. , 1990, Circulation.
[175] A. Yeung,et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.
[176] H. Drexler,et al. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. , 1989, Journal of the American College of Cardiology.
[177] P. Ganz,et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. , 1989, Circulation.
[178] E. Nabel,et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. , 1989, The Journal of clinical investigation.
[179] A. Simon,et al. Brachial arterial changes in response to wrist occlusion in normotensive and hypertensive men. , 1987, The American journal of physiology.
[180] P. Vanhoutte,et al. Antihypertensive Treatment Normalizes Decreased Endothelium‐Dependent Relaxations in Rats with Salt‐Induced Hypertension , 1987, Hypertension.
[181] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[182] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[183] Ryan A. Harris,et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. , 2011, American journal of physiology. Heart and circulatory physiology.
[184] G. Davey Smith,et al. Endothelial response to childhood infection: the role of mannose-binding lectin (MBL). , 2010, Atherosclerosis.
[185] L. Shaw,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[186] S. Priori,et al. European guidelines on cardiovascular disease prevention in clinical practice: full text , 2007 .
[187] T. L. Pinto,et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. , 2006, Cardiovascular revascularization medicine : including molecular interventions.
[188] Gian Paolo Rossi,et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. , 2005, Journal of hypertension.
[189] Gian Paolo Rossi,et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. , 2005, Journal of hypertension.
[190] L. Lerman,et al. Statin effects beyond lipid lowering--are they clinically relevant? , 2003, European heart journal.
[191] L. Ghiadoni,et al. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. , 2002, Drugs.
[192] I. Sartori. The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion: , 1996 .
[193] D. Betteridge,et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. , 1994, The Journal of clinical investigation.
[194] J. Hill,et al. Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited. , 1994, Circulation.
[195] T. Lüscher,et al. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. , 1991, The American journal of physiology.
[196] O. Hess,et al. Potential role of coronary vasoconstriction in ischaemic heart disease: effect of exercise. , 1990, European heart journal.
[197] E. Nabel,et al. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. , 1988, Circulation.